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Abstract Increased intracranial pressure is common in
cerebral venous thrombosis (CVT), but hydrocephalus is
rarely reported in these patients. We examined the frequen-
cy, pathophysiology and associated clinical manifestations
of hydrocephalus in patients with CVT admitted to our
hospital between 2000 and 2010 (prospectively since July
2006). Hydrocephalus was defined as a bicaudate index
larger than the 95th percentile for age, and/or a radial width
of the temporal horn of C5 mm. We excluded patients in
whom hydrocephalus was caused by a disease other than
CVT or if it was iatrogenic. 20 out of 99 patients with CVT
had hydrocephalus. 6 patients with hydrocephalus were ex-
cluded from the analysis. Patients with hydrocephalus more
often had focal neurological deficits (86 vs. 49 %, p = 0.02)
andweremore frequently comatose (43 vs. 16 %, p = 0.06),
as compared to patients without hydrocephalus. Deep cere-
bral venous thrombosis (64 vs. 9 %, p\ 0.001) and edema
of the basal ganglia and thalami (64 vs. 4 %, p\ 0.001)were
more common in patients with hydrocephalus. Intraven-
tricular hemorrhage was present in 1 patient with hydro-
cephalus, compared to none among patients without
hydrocephalus (7 vs. 0 %, p = 0.15). Outcome at follow-up
was worse in patients with hydrocephalus (mRS 0–1, 36 vs.
68 %, p = 0.02; mortality 29 vs. 9 %, p = 0.07). Hydro-
cephalus occurs more frequently in cerebral venous throm-
bosis than previously believed, especially in patients with
deep cerebral venous thrombosis and edema of the basal
ganglia. The presence of hydrocephalus is associated with a
worse clinical outcome, but a direct causal relation is un-
likely. Routine shunting procedures are not advisable.
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Introduction
Cerebral venous thrombosis (CVT) is a rare form of stroke
with an estimated incidence of 1.3 per 100.000 among
adults [1]. Thrombosis of the sinuses leads to impairment
of cerebral spinal fluid drainage and venous outflow, which
often causes increased intracranial pressure, with symp-
toms such as headache, papilledema and 6th nerve palsy
[2–4]. Hydrocephalus, however, is rarely reported in
patients with CVT and few studies have investigated this
complication. Cohort studies of CVT reported incidences
of hydrocephalus between 0.2 and 6.6 % [5–7]. However,
hydrocephalus was not a major research topic in any of
these studies and specific definitions or details are not
provided. All studies also lacked central review of imaging
data and the validity of the estimates provided by these
studies is, therefore, questionable. In fact, the only detailed
reports on hydrocephalus in patients with CVT are case
reports [8–12]. The aim of the present study was to sys-
tematically examine the incidence, risk factors, patho-
physiology, associated clinical manifestations, and
outcome of hydrocephalus in a large cohort of consecutive
patients with CVT.
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We included consecutive patients with CVT aged 12 and
older admitted to the Academic Medical Centre (University
of Amsterdam) between January 1st 2000 and January 1st
2011. Our hospital serves as a tertiary referral center for
CVT cases in the Netherlands. Since July 2006, all patients
with CVT are enrolled in a prospective database, as
described previously [13]. We retrospectively identified
patients admitted between January 1st 2000 and June 30th
2006, using the International Classification of Diseases, 9th
revision and the Dutch financial coding system for hospital
care [1]. CVT was confirmed in all patients by one of the
following—magnetic resonance imaging (MRI) with MRI-
venography, computed tomographic-venography (CT-V),
conventional angiography, or autopsy. We collected data
on demographics, baseline clinical characteristics, and
treatment. Clinical outcome was classified according to the
modified Rankin Scale (mRS), a 7-point scale which ranges
from 0 (complete recovery) to 6 (dead). We defined good
outcome as a mRS score of 0 or 1 at last follow-up. Patients
admitted before July 2006 for whom no mRS had been
recorded were contacted by telephone to determine the
score by means of a structured interview [14]. Under Dutch
law, ethical approval did not have to be obtained for this
observational study.
Imaging data and definition of hydrocephalus
All cerebral imaging results were re-evaluated by two
neuroradiologists (RvdB and CBM). The type of scan, lo-
cation of the thrombosis, presence and type of intracranial
lesions, and the presence of hydrocephalus were
documented. We determined the presence of hydrocephalus
by measuring the bicaudate index (BCI) and the radial
width of the temporal horn (rWTH), as described previously
[15, 16]. Briefly, the BCI is the width of the frontal horns at
the level of the caudate nuclei and the foramen of Monro
divided by the corresponding width of the brain at the same
level. To calculate age-adjusted relative sizes, the BCIs
were divided by the corresponding upper limit (95th per-
centile) per age group, as previously reported [16].
The rWTH of the lateral ventricle was measured at the
tip of the temporal horn on (axial) imaging using the
method described by Frisoni et al. [15]. The rWTH was
measured at the image slice where the temporal horn was
the widest. Two parallel lines were drawn tangential to the
margins of the temporal horn at its widest point. The rWTH
is the distance between the two lines. Because control
values for the rWTH have not been published, we mea-
sured the rWTH in a control group of healthy adults. For
each patient with CVT, we selected an age-matched control
patient who underwent cranial CT imaging because of a
minor head injury between 2010 and 2012. Only patients
without neurological co-morbidity and in whom the CT
scan was unremarkable (without any traumatic injuries)
were eligible as controls.
We defined hydrocephalus as one of the following—a
BCI above the 95th percentile for age, and/or a rWTH (uni-
or bilateral) 2.5 standard deviations or more above the
mean rWTH of the control group. Presence of hydro-
cephalus was determined on baseline imaging and on fol-
low-up scans performed within 30 days of diagnosis. If a
patient had hydrocephalus on multiple examinations, we
used the scan in which the hydrocephalus was most severe.
We excluded patients in whom hydrocephalus was caused
by a disease other than CVT or if it was deemed iatrogenic
(e.g. following decompressive hemicraniectomy).
Statistical analysis
For categorical variables, we used the Pearson v2 or Fish-
er’s exact test if appropriate. The Student’s t test or Mann–
Whitney test (for skewed distributions) were used for
continuous variables. To determine whether hydrocephalus
was associated with outcome, we performed multivariate
logistic regression analysis. All analyses were performed
with SPSS software, version 19.0.
Results
The mean rWTH in the age-matched control group (no
CVT) was 1.8 mm with a standard deviation of 1.2 mm.
Therefore, the upper limit of normal for the rWTH was
defined as 5 mm.
During the study period, 99 patients with CVT older
than 12 were admitted, of whom 59 after July 2006
(prospective cohort). Twenty of these patients (20 %) had
hydrocephalus (Fig. 1). Six patients were excluded from
the analysis because the hydrocephalus was iatrogenic or
had another cause [after decompressive hemicraniectomy
(3); complication of endovascular thrombolysis (2) and
hydrocephalus due to a teratoma (1)]. Therefore, the study
cohort consisted of 14 patients with and 79 patients without
hydrocephalus. In 10 of 14 patients (71 %) hydrocephalus
was present at baseline. In the remaining patients, hydro-
cephalus was found within 24 h of diagnosis (3 patients) or
8 days after diagnosis (1 patient). Thirteen patients (93 %)
had an increased rWTH (bilateral in 8) and only 2 (14 %)
had an increased BCI (Table 1). One patient had both an
increased BCI and rWTH. The mean rWTH was 6.5 mm in
the patients with hydrocephalus, compared to 2.1 mm in
those without hydrocephalus. At baseline, patients with
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hydrocephalus more often had focal neurological deficits
(86 vs. 49 %, p = 0.02), fixed and dilated pupil(s) (14 vs.
1 %, p = 0.06), and a lower Glasgow Coma Scale (median
10 vs. 15, p = 0.01) as compared to patients without hy-
drocephalus. Other baseline clinical characteristics did not
differ significantly. Lumbar puncture was performed in
four patients with hydrocephalus, and all had an increased
cerebrospinal fluid pressure ([20 cm H2O). In patients
without hydrocephalus, ten patients underwent lumbar
puncture and eight had an increased pressure.




rWTH radial width of the
temporal horn, BCI bicaudate








Increased rWTH 13/14 (93 %) – NA
Bilateral 8/14 (57 %) – NA
Mean rWTH (mm, SD) 6.5 (1.8) 2.1 (1.4) NA
Increased BCI 2/14 (14 %) – NA
Mean BCI (SD) 0.13 (0.04) 0.11 (0.03) NA
Hydrocephalus at baseline 10/14 (71 %) – NA
Demographics
Female 13/14 (93 %) 53/79 (67 %) 0.06
Mean age (SD) 33 (16) 37 (13) [0.1
Symptoms and signs
Duration symptom onset to diagnosis (days,
median, IQR)
5 (2–12) 4 (2–7) [0.1
Duration admission to diagnosis (days, median,
IQR)
0 (0–1) 1 (0–2) [0.1
Headache 13/14 (93 %) 67/79 (85 %) [0.1
Focal neurological deficit 12/14 (86 %) 38/77 (49 %) 0.02
Seizure(s) 3/14 (21 %) 27/79 (34 %) [0.1
Glasgow coma scale (median, IQR) 10 (8–14) 15 (11–15) 0.01
Coma 6/14 (43 %) 12/73 (16 %) 0.06
Fixed and dilated pupil(s) 2/14 (14 %) 1/79 (1 %) 0.06
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Patients with hydrocephalus more often had thrombosis
of the straight sinus (64 vs. 23 %, p = 0.002) and deep
cerebral venous thrombosis (DCVT: internal cerebral
veins, vein of Galen, and/or the basal vein of Rosenthal; 64
vs. 9 %, p\ 0.001, Table 2). In contrast, the superior
sagittal sinus was less often involved in patients with hy-
drocephalus (21 vs. 67 %, p = 0.001). Hypodensity of the
basal ganglia and/or thalami on CT, suggesting edema, was
present in 9/14 (64 %) patients with hydrocephalus, as
compared to 3/79 (4 %) in those without hydrocephalus
(p\ 0.001). In two of these nine patients, the presence of
edema was confirmed with MRI. There was no difference
in frequency of baseline intracerebral hemorrhages
between the two groups (50 vs. 54 %). One patient with
hydrocephalus had both supra and infratentorial localiza-
tion of the hemorrhage. Intraventricular extension of the
hemorrhage was present in one patient with hydrocephalus
at baseline, compared to none among patients without
hydrocephalus (7 vs. 0 %, p = 0.15). This patient had a
small amount of blood in the right occipital horn of the
lateral ventricle.
Three different patterns of hydrocephalus could be dis-
cerned. The largest group consisted of patients with an
increased rWTH, deep cerebral venous thrombosis and
edema of the basal ganglia and thalami (Fig. 2a, b). Nine of
the 14 patients with hydrocephalus fitted this pattern. The
BCI was normal in all of these patients, and only one had
thrombosis of the superior sagittal sinus. The next group
consisted of three patients with an increased unilateral
rWTH due to mass effect from a contralateral intracerebral
hemorrhage (Fig. 2c, d). Finally, two patients had an in-
creased BCI without parenchymal lesions or thrombosis of
the deep venous system. Both these patients had superior
sagittal sinus thrombosis, without involvement of the deep
veins.
Autopsy was performed in one patient with hydro-
cephalus and DCVT. Figure 3 shows a coronal section of
the brain demonstrating widening of the temporal horns
and small petechial hemorrhages and infarcts in the tha-
lami. The third ventricle and foramen of Monro were
narrowed.
All patients except one (in whom CVT was not diag-
nosed until autopsy) received treatment with therapeutic
doses of heparin (Table 2). Patients with hydrocephalus
more often were treated with endovascular thrombolysis
(64 vs. 18 %, p\ 0.001) and more often underwent de-
compressive hemicraniectomy (21 vs. 8 %, p[ 0.1). One
patient with hydrocephalus received an external ventricular
Table 2 Radiological findings, treatment and outcome
Hydrocephalus (n = 14) No hydrocephalus (n = 79) P value
Thrombosed sinuses
Superior sagittal sinus 3/14 (21 %) 53/79 (67 %) 0.001
Lateral sinus (left and/or right) 12/14 (86 %) 59/79 (75 %) [0.1
Straight sinus 9/14 (64 %) 18/78 (23 %) 0.002
Deep cerebral venous systema 9/14 (64 %) 7/79 (9 %) \0.001
Thrombosis[1 sinus 13/14 (93 %) 67/79 (85 %) [0.1
Parenchymal lesions
Edema basal ganglia/thalamib 9/14 (64 %) 3/79 (4 %) \0.001
Intracerebral hemorrhagic lesion 7/14 (50 %) 43/79 (54 %) [0.1
Intraventricular hemorrhage 1/14 (7 %) 0/79 (0 %) 0.15
Treatment
Heparin treatment 13/14 (93 %) 79/79 (100 %) [0.1
Endovascular treatment 9/14 (64 %) 14/78 (18 %) \0.001
Decompressive hemicraniectomy 3/14 (21 %) 6/78 (8 %) [0.1
Ventricular shunting procedure 1/14 (7 %) 2/79 (3 %) [0.1
Clinical outcome at last follow-up
Duration of follow-up (median months, IQR) 16 (2–75) 8 (4–24) [0.1
mRS 0–1 (recovery without handicap) 5/14 (36 %) 50/74 (68 %) 0.02
Mortality at follow-up 4/14 (29 %) 7/75 (9 %) 0.07
IQR interquartile range, mRS modified Rankin Scale
a Deep cerebral venous system was defined as thrombosis in one or more of the following veins: internal cerebral veins, vein of Galen, and basal
vein of Rosenthal
b Confirmed by MRI in 2/9 patients with hydrocephalus
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drain, which was done prior to the diagnosis of CVT. This
shunting procedure was done because of clinical worsening
(decrease in consciousness) and for diagnostic reasons. At
that time bacterial meningitis was considered the most
likely diagnosis and previous attempts to obtain cere-
brospinal fluid through lumbar puncture had failed. She
suffered from acute lymphoblastic leukemia, which was
diagnosed several hours after placement of the drain and
died as a result of a massive intraventricular hemorrhage
1 day after admission. No shunting procedures were per-
formed in any of the other patients with hydrocephalus.
Two patients without hydrocephalus received a ventricular
peritoneal drain because of intracranial hypertension with
severe papilledema and impending blindness. Both patients
recovered without visual loss.
Follow-up information on clinical outcome was avail-
able for 88 of the 93 patients (95 %). While the duration of
follow-up was non-significantly longer for patients with
hydrocephalus (16 vs. 8 months, p[ 0.1), patients with
hydrocephalus less often had a good outcome at last
available follow-up (36 vs. 68 %, p = 0.02). Mortality was
also higher in patients with hydrocephalus (29 vs. 9 %,
p = 0.07). After adjustment for baseline clinical imbal-
ances (gender, focal neurological deficits, coma, and fixed
pupils), however, hydrocephalus was not an independent
predictor of outcome (adjusted OR for mRS 0–1: 0.67,
95 % CI 0.15–2.92).
Fig. 2 Cerebral imaging of two
patients with hydrocephalus. a,
b Axial Fluid Attenuated
Inversion Recovery (FLAIR)
MRI showing extensive edema
in the thalami, basal ganglia and
brainstem, and hydrocephalus of
both temporal horns (arrows). c,
d Axial non-contrast-enhanced
CT scan of a different patient
showing a large space
occupying intracranial
hemorrhage in the left
hemisphere, and an increase of
width of the contralateral
temporal horn
Fig. 3 Autopsy of a patient with hydrocephalus. Coronal section of
the brain showing enlargement of the temporal horns (arrows). Small
petechial hemorrhages and infarcts are present bilaterally in the
thalami (arrowhead). The third ventricle and foramen of Monro are
narrowed
J Neurol (2015) 262:931–937 935
123
Discussion
This is the first study on hydrocephalus in a large cohort
of consecutive patients with cerebral venous thrombosis.
Our data show that hydrocephalus predominantly occurs
in patients with deep cerebral venous thrombosis and
edema of the basal ganglia and thalami. In all patients
with this pattern, the hydrocephalus is limited to the
temporal horns of the lateral ventricle. It is unlikely that
hydrocephalus in these patients is due to a diminished
resorption of cerebrospinal fluid by the arachnoid villi.
The majority of these villi are located in the superior
sagittal sinus, [17] which was rarely occluded in these
patients. A more plausible explanation and also consistent
with the pattern of hydrocephalus, is that the flow of
cerebrospinal fluid (CSF) through the foramen of Monro
is obstructed due to local compression by edema of the
basal ganglia and/or thalami. The autopsy results are in
agreement with this hypothesis. Considering the pivotal
role of the arachnoid villi in the drainage of CSF, one
may wonder why CVT does not result in hydrocephalus
more often, especially in cases with thrombosis of the
superior sagittal sinus. Many of these patients have in-
creased intracranial pressure, but hydrocephalus occurred
only in 2/55 patients with thrombosis of the superior
sagittal sinus in our cohort. The most likely explanation
is that there is no pressure gradient of the CSF in these
cases between the ventricular and subarachnoid com-
partments at the cerebral convexity. A similar mechanism
has been proposed in patients with cryptococcal menin-
gitis and increased intracranial pressure, who generally
also do not have hydrocephalus [18]. Intraventricular
extension of hemorrhage may also be a contributing
factor to the development of hydrocephalus, but this
occurred only in one patient.
The frequency of hydrocephalus was much higher in our
cohort than previously reported [5–12]. There are two
possible explanations for this disparity. First, our hospital is
a tertiary referral center for patients with a severe form of
CVT. 21 % of our patients was in coma at baseline and
17 % had DCVT, which is both higher than in other cohort
studies [2, 19]. A second explanation is that most studies
did not focus on hydrocephalus, which probably leads to an
underestimation of its frequency.
Despite aggressive treatment with endovascular throm-
bolysis and decompressive hemicraniectomy in many
patients, hydrocephalus was associated with a high risk of
poor outcome. After correction for baseline imbalances,
however, hydrocephalus was not an independent predictor
of outcome. Hydrocephalus is probably a marker of a
severe form of CVT, associated with edema of the basal
ganglia/thalami caused by DCVT. DCVT is a well-known
predictor of poor outcome [2]. Since a causal relation
between hydrocephalus and poor outcome is unlikely, the
risks of shunting procedures and the fact that patients with
CVT require treatment with anticoagulation, we do not
recommend routine shunting procedures in patients with
CVT and hydrocephalus. Generally, we will only consider
an external ventricular drain in these patients if they are in
a worse clinical condition than would be expected on the
extent of the parenchymal lesions or if they deteriorate
without apparent cause other than the hydrocephalus. In
patients who additionally have seizures, the decision
whether or not to perform a shunting procedure is even
more difficult, since these patients often have fluctuations
in their consciousness. The other situation when a shunting
procedure should be considered in CVT is in patients with
severe intracranial hypertension (usually without hydro-
cephalus) that comprises visual function or, rarely, cerebral
perfusion.
Our study has some limitations—first, the rWTH is less
often used for the determination of hydrocephalus than the
BCI. Since cutoff values for a normal rWTH were not
available in the literature, we determined the upper normal
value by measuring the rWTH in a cohort of age-matched
patients. Another limitation is that MRI—which is clearly
superior to determine the extent of edema of the basal
ganglia—was only available in a minority of patients.
Finally, in a subset of patients, the data were collected
retrospectively. However, since all imaging data were
re-evaluated and outcome was available for almost all
patients, we do not think this influences the validity of the
results.
In conclusion, we found that hydrocephalus is more
common in patients with cerebral venous thrombosis than
previously believed. Hydrocephalus mainly occurs in
patients with deep cerebral venous thrombosis and edema
of the basal ganglia and thalami, probably because of
obstruction of the foramen of Monro. The presence of
hydrocephalus is associated with a worse clinical outcome,
but a direct causal relation is unlikely. Routine shunting
procedures are, therefore, not recommended in these
patients.
Acknowledgments JMC is supported by ‘‘The Netherlands Orga-
nisation for Scientific Research’’ (NWO), grant number 021.001.045
and the Dutch Thrombosis Society, grant number 2012-2, and the
Netherlands Brain Foundation.
Conflicts of interest All authors stated that there are no conflicts of
interest regarding the publication of this article.
Ethical standard Under Dutch law, ethical approval did not have to
be obtained for this observational study.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
936 J Neurol (2015) 262:931–937
123
References
1. Coutinho JM, Zuurbier SM, Aramideh M, Stam J (2012) The
incidence of cerebral venous thrombosis: a cross-sectional study.
Stroke 43:3375–3377
2. Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F
(2004) Prognosis of cerebral vein and dural sinus thrombosis:
results of the International Study on Cerebral Vein and Dural
Sinus Thrombosis (ISCVT). Stroke 35:664–670
3. Stam J (2005) Thrombosis of the cerebral veins and sinuses.
N Engl J Med 352:1791–1798
4. Bousser MG, Ferro JM (2007) Cerebral venous thrombosis: an
update. Lancet Neurol 6:162–170
5. Nasr DM, Brinjikji W, Cloft HJ, Saposnik G, Rabinstein AA
(2013) Mortality in cerebral venous thrombosis: results from the
national inpatient sample database. Cerebrovasc Dis 35:40–44
6. Narayan D, Kaul S, Ravishankar K, Suryaprabha T, Bandaru VC,
Mridula KR, Jabeen SA, Alladi S, Meena AK, Borgohain R
(2012) Risk factors, clinical profile, and long-term outcome of
428 patients of cerebral sinus venous thrombosis: insights from
Nizam’s Institute Venous Stroke Registry, Hyderabad (India).
Neurol India 60:154–159
7. Wasay M, Bakshi R, Bobustuc G, Kojan S, Sheikh Z, Dai A,
Cheema Z (2008) Cerebral venous thrombosis: analysis of a
multicenter cohort from the United States. J Stroke Cerebrovasc
Dis 17:49–54
8. Weidauer S, Marquardt G, Seifert V, Zanella FE (2005) Hydro-
cephalus due to superior sagittal sinus thrombosis. Acta Neu-
rochir (Wien) 147:427–430
9. Kourtopoulos H, Christie M, Rath B (1994) Open thrombectomy
combined with thrombolysis in massive intracranial sinus
thrombosis. Acta Neurochir (Wien) 128:171–173
10. Spearman MP, Jungreis CA, Wehner JJ, Gerszten PC, Welch WC
(1997) Endovascular thrombolysis in deep cerebral venous
thrombosis. AJNR Am J Neuroradiol 18:502–506
11. Mullen MT, Sansing LH, Hurst RW, Weigele JB, Polasani RS,
Messe SR (2009) Obstructive hydrocephalus from venous sinus
thrombosis. Neurocrit Care 10:359–362
12. Stavrinou LC, Stranjalis G, Bouras T, Sakas DE (2008) Trans-
verse sinus thrombosis presenting with acute hydrocephalus: a
case report. Headache 48:290–292
13. Coutinho JM, van den Berg R, Zuurbier SM, Vanbavel E, Troost
D, Majoie CB, Stam J (2014) Small juxtacortical hemorrhages in
cerebral venous thrombosis. Ann Neurol 75:908–916
14. Bruno A, Akinwuntan AE, Lin C, Close B, Davis K, Baute V,
Aryal T, Brooks D, Hess DC, Switzer JA, Nichols FT (2011)
Simplified modified rankin scale questionnaire: reproducibility
over the telephone and validation with quality of life. Stroke
42:2276–2279
15. Frisoni GB, Geroldi C, Beltramello A, Bianchetti A, Binetti G,
Bordiga G, DeCarli C, Laakso MP, Soininen H, Testa C, Zanetti
O, Trabucchi M (2002) Radial width of the temporal horn: a
sensitive measure in Alzheimer disease. AJNR Am J Neuroradiol
23:35–47
16. Kasanmoentalib ES, Brouwer MC, van der Ende A, van de Beek
D (2010) Hydrocephalus in adults with community-acquired
bacterial meningitis. Neurology 75:918–923
17. Kapoor KG, Katz SE, Grzybowski DM, Lubow M (2008) Cere-
brospinal fluid outflow: an evolving perspective. Brain Res Bull
77:327–334
18. Denning DW, Armstrong RW, Lewis BH, Stevens DA (1991)
Elevated cerebrospinal fluid pressures in patients with crypto-
coccal meningitis and acquired immunodeficiency syndrome. Am
J Med 91:267–272
19. Wasay M, Saadatnia M, Venketasubramanian N, Kaul S, Menon
B, Gunaratne P, Malik A, Mehmood K, Ahmed S, Awan S,
Mehndiratta MM (2012) Predictors of cerebral venous thrombo-
sis and arterial ischemic stroke in young Asian women. J Stroke
Cerebrovasc Dis 21:689–694
J Neurol (2015) 262:931–937 937
123
